EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial

Rong Dai, Changkai Deng

World Journal of Urology · 2024

DOI: 10.1007/s00345-024-05025-x ↗

Kurz gefasst

Leserbrief in der Zeitschrift World Journal of Urology, 2024. Verfasst von Rong Dai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Chengdu Center for Disease Control and Prevention, Chengdu, 610041, China. Hauptthemen laut MEDLINE: Acetanilides, Cross-Over Studies, Thiazoles, Urinary Bladder, Overactive. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetanilidesCross-Over StudiesThiazolesUrinary Bladder, OveractiveAdultAgedFemaleHumansMiddle AgedAdrenergic beta-3 Receptor AgonistsProspective StudiesPyrimidinonesPyrrolidinesTreatment OutcomeUrological AgentsMulticenter Studies as TopicRandomized Controlled Trials as Topic

Substanzen

AcetanilidesAdrenergic beta-3 Receptor AgonistsmirabegronN-(4-((5-(hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo(1,2-a)pyrimidine-6-carbo…PyrimidinonesPyrrolidinesThiazolesUrological Agents

Autor:innen und Institutionen

  • Chengdu Center for Disease Control and Prevention, Chengdu, 610041, China.
  • Department of Pediatric Surgery, School of Medicine, Chengdu Women's and Children's Central Hospital, University of Electronic Science and Technology of China, Chengdu, 611731, China. 15882420198@163.com.

Zitieren

APA

Dai, R., & Deng, C. (2024). Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial. World Journal of Urology. https://doi.org/10.1007/s00345-024-05025-x

Vancouver

Dai R, Deng C. Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial. World Journal of Urology. 2024. doi:10.1007/s00345-024-05025-x

BibTeX
@article{Dai2024,
  author = {Dai, Rong and Deng, Changkai},
  title = {Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial},
  journal = {World Journal of Urology},
  year = {2024},
  doi = {10.1007/s00345-024-05025-x}
}
Kostenlos starten →